Vaksin Covid-19 Oxford–AstraZeneca: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Lembar kemajuan Tag: Suntingan perangkat seluler Suntingan peramban seluler |
Membalikkan revisi 21731564 oleh 2404:C0:7040:0:0:0:3F45:3A06 (bicara) Tag: Pembatalan |
||
Baris 1:
{{update}}
{{Infobox drug
| Verifiedfields =
Baris 44:
}}
{{COVID-19 pandemic sidebar|expanded=medis}}
'''Vaksin Covid-19 Oxford–AstraZeneca''', juga dikenal sebagai '''AZD1222''', adalah sebuah [[vaksin COVID-19]] yang dikembangkan oleh [[Universitas Oxford]] dan [[AstraZeneca]] yang diberikan lewat [[suntikan intraotot]].<ref>{{cite news |last1=Walsh |first1=Nick |last2=Shelley |first2=Jo |last3=Duwe |first3=Eduardo |last4=Bonnett |first4=William | name-list-style = vanc |date=27 July 2020 |title=The world's hopes for a coronavirus vaccine may run in these health care workers' veins |url=https://edition.cnn.com/2020/07/27/americas/brazil-covid-19-sinovac-vaccine-intl/index.html |work=[[CNN]] |location=[[São Paulo]] |access-date=3 August 2020 |archive-date=3 August 2020 |archive-url= https://web.archive.org/web/20200803211040/https://edition.cnn.com/2020/07/27/americas/brazil-covid-19-sinovac-vaccine-intl/index.html |url-status=live }}</ref><ref name="NCT04400838">{{cite web |title=Investigating a Vaccine Against COVID-19 |url=https://clinicaltrials.gov/ct2/show/NCT04400838 |website=[[ClinicalTrials.gov]] |publisher=[[United States National Library of Medicine]] |type=Registry |id=NCT04400838 |date=26 May 2020 |access-date=14 July 2020 |archive-date=11 October 2020 |archive-url=https://web.archive.org/web/20201011084750/https://clinicaltrials.gov/ct2/show/NCT04400838/ |url-status=live }}</ref><ref name="EudraCT-2020-001228-32">{{cite web |url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB |title=A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 |website=EU Clinical Trials Register |publisher=European Union |type=Registry |id=[[EudraCT]] 2020-001228-32 |date=21 April 2020 |access-date=3 August 2020 |archive-date=5 October 2020 |archive-url=https://web.archive.org/web/20201005201654/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB |url-status=live }}</ref><ref name="ISRCTN89951424">{{cite journal |title=A Phase III study to investigate a vaccine against COVID-19 |website=ISRCTN |type=Registry |id=ISRCTN89951424 |doi=10.1186/ISRCTN89951424 |date=26 May 2020 | vauthors = O'Reilly P | doi-access=free }}</ref> Risetnya dilakukan oleh [[Jenner Institute]] dan [[Oxford Vaccine Group]] dari Universitas Oxford. Timnya dipimpin oleh [[Sarah Gilbert]], [[Adrian V. S. Hill|Adrian Hill]], [[Andrew Pollard (pakar biologi)|Andrew Pollard]], [[Teresa Lambe]], Sandy Douglas dan [[Catherine M. Green|Catherine Green]].<ref>{{Cite web|url=https://covid19vaccinetrial.co.uk/|title=COVID-19 Vaccine Trials {{!}} COVID-19|website=covid19vaccinetrial.co.uk|access-date=2020-04-11}}</ref><ref>{{Cite web|last=|first=|date=2020-02-07|title=Oxford team to begin novel coronavirus vaccine research|url=https://www.ox.ac.uk/news/2020-02-07-oxford-team-begin-novel-coronavirus-vaccine-research|url-status=live|archive-url=|archive-date=|access-date=2020-11-28|website=University of Oxford|language=en}}</ref> Pada Desember 2020, kandidat vaksin tersebut menjalani [[riset klinis Tahap III]]. Pada 30 Desember 2020, vaksin tersebut disepakati untuk dipakai<ref>{{cite web |title=Covid-19: Oxford-AstraZeneca coronavirus vaccine approved for use in UK |url=https://www.bbc.co.uk/news/health-55280671 |website=BBC News |publisher=BBC |access-date=30 December 2020 |date=30 December 2020}}</ref> dalam program vaksinasi Britania Raya.
== Kontraindikasi ==
|